U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948799) titled 'A Study to Evaluate the Safety and Tolerability of Multiple Dose of STSP-0902 in Healthy Subjects' on April 21.
Brief Summary: This is a Phase 1b, randomized, double-blind, placebo-controlled, multiple ascending dose (MAD) study to evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of STSP-0902
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Oligozoospermia
Intervention:
DRUG: STSP-0902 injection
Subjects will receive the administration dose on Day 1 following protocol requirements
DRUG: Placebo
Subjects will receive the administration dose on Day 1 following protocol requirement...